CTTN and breast carcinoma: Mass spectrometry (MS) analyses of anti-ROR1 mAb immune precipitates (i.p.)from lysates of ROR1-expressing breast-cancer PDX revealed cortactin in addition to ROR1 (Fig. 1a).